home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance both economic and technical to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.


For further information please contact:

Jonathan Smith

Charlie Burgon

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

View the digital version of EPC


Featured in this issue
Event Review: PCMG Conference

Inside Out

EPC Editor Graham Hughes reports back from the recent PCMG Confernce held in Warsaw, divulging the lessons learnt from presentations given by speakers from within and outside of the industry

Data Management & IT Solutions
Data Mergers

Big Data Meets Big Pharma

Citing a collection of the 'value-added partnerships' that have arisen in recent times, GlobalData's Adam Dion discusses the broad appeal of big data for life sciences companies. With data analytics and cloud computing continuing to develop, collaborative efforts are sure to become common practice.
  Legal & Regulatory
Regulatory Pathways

Common Cause

Steffen Thirstrup
from NDA urges pharma companies to adopt a revised and more integrated approach to market entry. The onset of the adaptive pathway provides the perfect opportunity to lose old habits, rightfully placing consumers at the forefront of their focus.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December

Banner of ESMO.EPC on Samedan
Banner of Inform.EPC on Samedan
Industry Events

The Pharmaceutical and Medical Device Labelling Summit

27-28 October 2015, Maritim proArte Hotel Berlin

Optimise Your Labelling Strategies to Ensure Accurate Product Information and Successful Regulatory Compliance. 1 Event, 2 Streams. Join us in Berlin this October to benefit from industry leaders providing their experience and expertise within this complex and ever-changing landscape.
More info >>

News and Press Releases

Advancia a next generation spray from Nemera is now in production with an annual capacity of 45 million units

Nemera has invested more than 10 million euros in R&D and manufacturing to launch the only user-independent multi-dose nasal spray system on the market.
More info >>

air transport logo


White Papers

galenIQ - The smart excipient

BENEO-Palatinit GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement